A new large study has found that about one in six people may experience withdrawal symptoms after they stop taking ...

The Citizens Commission on Human Rights International (CCHR) says a landmark article published in Psychiatric Times confirms ...

Last month I wrote an open letter, as Chair of the International Institute of Psychiatric Drug Withdrawal, requesting that the UK’s National Institute for Health and Care Excellence (NICE) reverse its ...

UPMC is one of the first health systems to write a blueprint for treating patients experiencing gruesome side effects from drugs laced with xylazine. Xylazine is not an opioid. It's an animal ...

The substances abused must be determined early in treatment, because there are substantial differences in severe complications and in the management of withdrawal from alcohol and sedatives, opiates, ...

Finerenone, a third-generation nonsteroidal mineralocorticoid receptor antagonist, showed promise in reducing the incidence of cardiovascular events in patients with heart failure (HF). However, its ...